Affiliation:
1. Department of Pharmaceutical Chemistry, Government College University, Faisalabad, Pakistan
2. Department of Pharmacy, The Women University, Multan, Pakistan
Abstract
Abstract:
Resveratrol (RSV) is known as a natural polyphenolic compound that is known for its therapeutic activities but has limited bioavailability. The aim of our study was to explore various drug-delivering methods that are being employed to achieve target-oriented delivery and therapeutic performance of RSV. To improve the bioavailability and pharmacokinetic properties of RSV, efforts are being made by producing efficient formulations accompanying efficient drug delivery strategies. Several clinical trial studies have been conducted on RSV isomers, and the majority of studies indicated that trans-RSV had better clinical potential and therapeutic effectiveness in various types of complications such as colorectal cancer, metabolic syndrome, hypertension, obesity, neurodegenerative diseases, diabetes, hepatic disease, cardiac disorders, and breast cancer. However, multiple research studies enable us to understand various strategies that can enhance the systemic availability and efficacy of topical RSV formulations. In this article, we emphasize the hurdles of RSV delivery processes. We summarized that for delivering liquid and solid microparticles of RSV, the micro-particulate system works efficiently. Another technique in which particles are enclosed by a coating is called microencapsulation. This technique reduces the degradation of pharmaceutical compounds. Similarly, the cyclodextrin system is mainly used for poorly soluble drugs. On the other hand, the vesicular system is another micro-particulate system that can encapsulate hydrophilic and hydrophobic drugs. However, the RSV nanosponge formulations have advanced nanodrug delivery systems also make it possible to use RSV for its antioxidant potential.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology
Reference91 articles.
1. Hu M.; Ge X.; Chen X.; Mao W.; Qian X.; Yuan W.E.; Micro/nanorobot: A promising targeted drug delivery system. Pharmaceutics 2020,12(7),665
2. Amri A.; Chaumeil J.C.; Sfar S.; Charrueau C.; Administration of resveratrol: What formulation solutions to bioavailability limitations? J Control Release 2012,158(2),182-193
3. De Santi C.; Pietrabissa A.; Spisni R.; Mosca F.; Pacifici G.M.; Sulphation of resveratrol, a natural compound present in wine, and its inhibi-tion by natural flavonoids. Xenobiotica 2000,30(9),857-866
4. Frémont L.; Biological effects of resveratrol. Life Sci 2000,66(8),663-673
5. Aggarwal B.B.; Bhardwaj A.; Aggarwal R.S.; Seeram N.P.; Shishodia S.; Takada Y.; Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res 2004,24(5A),2783-2840
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献